Skip to main content
. 2022 Mar 31;10(4):541. doi: 10.3390/vaccines10040541

Table 1.

Sociodemographic characteristics of participants.

Variables n = 1445
n (%)
Gender
Male 1282 (88.7)
Female 163 (11.3)
Age
18–20 465 (32.2)
>20 980 (67.8)
Nationality
Saudi 1428 (98.8)
Non-Saudi 17 (1.2)
Place of residence
Central region 1291 (89.3)
Others 154 (10.7)
Your university
King Saud University 802 (55.5)
King Saud Bin Abdulaziz University for health science 316 (21.9)
Imam Mohammad Bin Saud Islamic University 282 (19.5)
Others 45 (3.1)
Current year
Pre-Clinical Years 683 (47.3)
Clinical Years 762 (52.7)
Family income
<5000 43 (3)
5000–20,000 465 (32.2)
>20,000 937 (64.8)
Which vaccine did you receive?
I didn’t get the vaccine 231 (16)
BioNTech/Pfizer and Oxford-AstraZeneca 376 (26)
BioNTech/Pfizer 625 (43.3)
Oxford-AstraZeneca 189 (13.1)
Others 24 (1.7)
Have you ever been infected with COVID-19?
Yes 217 (15)
No 1150 (79.6)
I don’t know 78 (5.4)